I coordinate operations throughout 14 states on behalf of the Bavenico and Xalkori prescription brands by overseeing recruitment and hiring across seven oncology territory managers in the West Area, and successful alliance partnerships with Pfizer district sales managers and teams. I also serve as an advisory board member on the global Academy for Commercial Excellence (ACE) Leadership Summit, as well as an ABD lead for additional on-boarding functions during recent expansions covering 13 territory managers. I similarly encourage high productivity levels through self-created area sales contests while also maintaining positive workplace culture based on increased performance, trust, and teamwork. Lastly, I provided mentorship and coaching to oncology territory managers.While employed in this role, I made the following special contributions:◆ I received multiple SPOT and OWN IT awards—as well as the 2017 Elite Award—in recognition for outstanding service; I similarly achieved #2 ranking for area sales performance in 2017 with a new team and area.◆ I completed the required Strategic Thinking Course and PCI Advanced Coaching Center.◆ I assisted with building the EMD oncology division from the ground up, as well as the launch of Avelumab (Bavencio) in Metastatic Merkel Cell Carcinoma and Locally Advanced or Metastatic Urothelial Carcinoma.◆ I assisted assisted in the creation of the incentive compensation plan for the company’s field team in 2017 and 2018.

I maintained and expanded on an oncology portfolio cataloguing six products, and organized sales through nine account managers across seven states. I similarly coordinated recruiting, interviewing and hiring processes for sales representatives in the West Sector, and provided comprehensive training for two regional sales managers. Participated in the company's Dabrafenib (Tafinlar) and Trametinib (Mekinist) Launch Planning & Execution Team, as well as the Enterprise Field Business Planning Committee representing first-line leadership. In turn, I conducted monthly conversations with the head of compliance for national oncology matters, and tasked with the roll-out of reminders or new updates to the West Area. Lastly, I guided resource management including strategic budget rollout per territory—and speaker programs with key audiences—to drive product awareness and home office interactions.While employed in this role, I made the following special contributions:◆ I moderated approximately $18M of West Area portfolio revenue.◆ I facilitated the creation and rollout of the Oncology BU Rewards & Recognition Program to improve recognition, performance, and overall business culture.

I directed product sales at various oncology clinics and hospitals within Missouri and Kansas including a multi-tyrosine kinase inhibitor for the treatment of advanced renal cell carcinoma, a kinase inhibitor for the treatment of HER+ breast cancer, and a topoisomerase inhibitor for patients with ovarian, cervical, or small cell lung cancer. I also served as a member of the Tykerb Marketing Advisory Board, and as the leader of the company’s Regional Specialty Pharmacy Initiative to help identify specialty pharmacies within the region and increase awareness of side effects created by company-produced drugs. In turn, I boosted patient compliance and duration of treatments via additional assistance with marketing and development for patient education pieces designed for specialty pharmacies tied to the initiative.While employed in this role, I made the following special contributions:◆ I ranked in the top 10% for portfolio growth (with a significant rise from the bottom 10%) in 2009, and the top three for national Hycamtin IV Sales in 2010.◆ I offered services as a guest trainer at the 2010 National BU Meeting.◆ I earned multiple selections as a “High 5” Award Recipient for Achieving Excellence.

I acted as a primary contact for cardiology, urology, and endocrinology accounts focusing on heart failure, high blood pressure, benign prostatic hyperplasia, and Type 2 diabetes. I similarly provided additional services to the key opinion leaders (KOLs) and guided the successful development and execution of a 13-week routing tool designed to uphold representatives' accountability for--and communication with--key customers via weekly tracking and performance evaluations. In turn, I participated in national speaker development of two KOLs covering three high-profile brands while also serving as a regional field advisor and analyst. While employed in this role, I made the following special contributions:◆ I served on the Field Advisory Board for Heart of America Region in 2007, and the Field Advisory Board for Avodart in 2008; I also served as a regional field advisor for digital sales technology-related operations.◆ I ranked in the top 25% for portfolio achievement in 2008.

I oversaw the sales of specialized cardiovascular products to various clients. I also maintained up-to-date clinical data via regular contact with relevant industry representatives, and cultivated ongoing business relationships with key physicians, hospital nurses, and medical technicians. In turn, I identified competitive advantages by directly monitoring and analyzing then-current market data and conditions.While employed in this role, I made the following special contributions:◆ I earned top 25% national ranking in 2006 for comprehensive goal attainment (achieving 111% of established goals); I similarly awarded the 2006 Avandia ADOPT special incentive.◆ I completed the Regional Development Program in 2006 to assess key skills and areas for development concerning specific scenarios necessitating critical thinking, coaching, and conflict management role-playing.